Overview

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S